VILINBIO logo

Vilin Bio Med Limited Stock Price

NSEI:VILINBIO Community·₹272.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VILINBIO Share Price Performance

₹19.50
-0.55 (-2.74%)
₹19.50
-0.55 (-2.74%)
Price ₹19.50

VILINBIO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

Vilin Bio Med Limited Key Details

₹199.8m

Revenue

₹186.8m

Cost of Revenue

₹13.0m

Gross Profit

₹10.5m

Other Expenses

₹2.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.18
6.51%
1.26%
2.0%
View Full Analysis

About VILINBIO

Founded
2005
Employees
n/a
CEO
Madhusudhan Reddy
WebsiteView website
www.vilinbiomed.co.in

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food supplements. It sells its products in bulk to pharmaceuticals manufacturers, marketers, and traders. Vilin Bio Med Limited was incorporated in 2005 and is based in Hyderabad, India.

Recent VILINBIO News & Updates

Recent updates

No updates